Protein Summary
Cooperates with LY96 and CD14 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) (PubMed:27022195). Acts via MYD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:9237759, PubMed:10835634, PubMed:27022195). Also involved in LPS-independent inflammatory responses triggered by free fatty acids, such as palmitate, and Ni(2+). Responses triggered by Ni(2+) require non-conserved histidines and are, therefore, species-specific (PubMed:20711192). Both M.tuberculosis HSP70 (dnaK) and HSP65 (groEL-2) act via this protein to stimulate NF-kappa-B expression (PubMed:15809303). In complex with TLR6, promotes sterile inflammation in monocytes/macrophages in response to oxidized low-density lipoprotein (oxLDL) or amyloid-beta 42. In this context, the initial signal is provided by oxLDL- or amyloid-beta 42-binding to CD36. This event induces the formation of a heterodimer of TLR4 and TLR6, which is rapidly internaliz ...more
- ENST00000355622
- ENSP00000363089
- ENSG00000136869
- ENST00000394487
- ENSP00000377997
- ENST00000645071
- ENSP00000494590
- TOLL
- CD284
- TLR-4
- ARMD10
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
biological process | 1 | ||
chemical | 0.97 | ||
protein domain | 0.92 | ||
disease | 0.86 | ||
phenotype | 0.8 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 12417.52 (req: < 5)
Gene RIFs: 2409 (req: <= 3)
Antibodies: 1695 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 12417.52 (req: >= 5)
Gene RIFs: 2409 (req: > 3)
Antibodies: 1695 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 87
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 37
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 1